Biosimilar Development is devoted to sharing technical insights and thought-leadership articles about advancements in biosimilar research, regulations, policy, and commercialization in the global biosimilar field.
As an active participant on the biosimilar conference circuit, Chief Editor Anna Rose Welch has been named chair, speaker, and panel moderator at events in the United States and Europe, such as World Biosimilar Congress USA, The Biotech Pharma Summit, CBI Biosimilars Summit, DIA Biosimilars Conference, and Biosimilar Medicines Group Conference.
In this article, George I’ons, head of product strategy and insights at Owen Mumford, discusses some of the major factors companies should consider regarding device platforms. Find the complete story here.